Moneycontrol PRO
HomeNewsBusinessSell Ajanta Pharma, target Rs 900: Ashish Chaturmohta

Sell Ajanta Pharma, target Rs 900: Ashish Chaturmohta

"The stock can be sold at current level and on the rise up to Rs 1,000 with a stop loss above Rs 1,030 for a target of Rs 900 levels," says Ashish Chaturmohta of Sanctum Wealth Management.

May 22, 2018 / 11:12 IST
Aurobindo Pharma Ltd.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Ashish Chaturmohta

    Ajanta Pharma has formed a major bearish head and shoulders reversal pattern on its monthly chart. The price has witnessed a breakout on the downside from pattern. The volumes have been above average and price erosion in last three weeks indicating selling pressure in the stock.

    Weekly ADX line has turned up after being flat for the last four months indicating strength in a downtrend. The weekly MACD too has moved below neutral level of zero indicating a resumption of the downtrend. Any bounce back is a shorting opportunity in the stock.

    Thus, the stock can be sold at current level and on the rise up to Rs 1,000 with a stop loss above Rs 1,030 for a target of Rs 900 levels.

    Disclaimer: The author is Head Technical and Derivatives, Sanctum Wealth Management. The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Moneycontrol News
    first published: May 22, 2018 11:12 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347